About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2025 Clareo Health. All rights reserved.

Dupilumab for Severe Asthma in a Real Life Setting | Clinical Trials | Clareo Health

COMPLETED

Dupilumab for Severe Asthma in a Real Life Setting

Dupilumab Effectiveness in Severe Asthma: a Cohort Study From a Nationwide Early Access

NCT04022447•Assistance Publique - Hôpitaux de Paris

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Severe Asthma

Interventions

Dupilumab

Locations

1

France

Locations (1)

Bichat-Claude Bernard University Hospital

Paris, France

Key Dates

Start Date

August 10, 2018

Primary Completion Date

April 2, 2019

Completion Date

April 2, 2019

Last Updated

August 6, 2019

Related Studies

Early High-flow Oxygen Therapy With nebuLized Beta-2-agonist Using a Vibrating Mesh for the Management of Moderate to Severe Asthma Exacerbation in the Emergency Department

NCT05691218

Moderate Asthma ExacerbationSevere Asthma Exacerbation

Exploring the Lived Experience of Young Adults With Severe Asthma

NCT06681545

AsthmaSevere Asthma+1 more

RECRUITINGPhase 4

Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping

NCT06385236

Moderate to Severe Asthma

Enrolling By InvitationPhase 4

Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA

NCT07343661

EGPA - Eosinophilic Granulomatosis With PolyangiitisSevere Asthma+1 more

Enrolling By Invitation

Impact of Respiratory Allergy on Response to Initiation of Biotherapy in Severe Asthma in Adult Severe Asthmatic Patients Followed at Poitiers University Hospital on Biotherapy

NCT06916104

Severe AsthmaBiotherapy+1 more

Not Yet RecruitingPhase 2

Phase II Trial of RC1416 Injection in Asthma

NCT07403487

Moderate to Severe Asthma

View all related studies

Sponsors

Lead Sponsor

Assistance Publique - Hôpitaux de Paris

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 6, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions